Literature DB >> 1522551

Immunosuppressive therapy in the treatment of immune-mediated disease.

E Miller1.   

Abstract

Immune-mediated diseases represent some of the most frustrating types of disorders that are diagnosed and treated in veterinary medicine. Drug-induced immunosuppression is an attempt to control the aberrant immune response against self antigens but the immunosuppression can result in sepsis or other unacceptable adverse effects. If the pathophysiology of immune-mediated and autoimmune disease is considered, the immune response can be divided into several components and attempts can be made to selectively deal with each component separately. The components of the immune response that can be manipulated by therapy include antibodies, effector cells, the mononuclear phagocytic system, and the peripheral manifestations of disease. This article reviews the therapy of immune-mediated and autoimmune diseases based on a pathophysiologic approach and discusses conventional as well as current therapies in the treatment of these devastating diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522551     DOI: 10.1111/j.1939-1676.1992.tb00340.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  Immunosuppressive drug therapy.

Authors:  P M Dowling
Journal:  Can Vet J       Date:  1995-12       Impact factor: 1.008

2.  The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogs.

Authors:  N E Rinkardt; S A Kruth; A Kaushik
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

3.  Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy.

Authors:  Rafaela de Sousa Gonçalves; Flaviane Alves de Pinho; Ricardo Jorge Dinis-Oliveira; Rui Azevedo; Joana Gaifem; Daniela Farias Larangeira; Eduardo Milton Ramos-Sanchez; Hiro Goto; Ricardo Silvestre; Stella Maria Barrouin-Melo
Journal:  Microorganisms       Date:  2020-05-15

Review 4.  Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases.

Authors:  Shing Yi Pan; Yvonne Cashinn Chia; Hui Rong Yee; Angelina Ying Fang Cheng; Clarice Evey Anjum; Yenny Kenisi; Mike Ks Chan; Michelle Bf Wong
Journal:  Future Sci OA       Date:  2020-10-29

5.  Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases.

Authors:  Masahiko Sato; Julia K Veir; Sarah B Shropshire; Michael R Lappin
Journal:  J Vet Intern Med       Date:  2020-04-08       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.